ImmuLogic, Hoechst Marion Roussel Inc. deal

HMR withdrew from its 1992 partnership to develop IMUL's Allervax product line, returning to IMUL all rights to the allergy treatments outside the U.S. HMR said the decision reflected its ongoing reas...